ERBB2 and gastric cancer: A case report on [68Ga]Ga-HER2-Affibody imaging of a 40-year-old woman with advanced metastatic gastric cancer published by the same authors was consistent with these results [74] and highlighted the superior ability of Affibody imaging compared to [18F]FDG PET in the detection of metastases in this patient.